Literature DB >> 19379184

Hypertrophic osteopathy secondary to pulmonary sarcoma in a cat.

J M Grierson1, C A Burton, M J Brearley.   

Abstract

A case of hypertrophic osteopathy secondary to a pulmonary spindle cell sarcoma is described. The 9-year-old male cat presented with a 1-month history of decreased appetite, decreased activity and progressive lameness with swelling and pain of all four limbs. Thoracic radiographs showed a soft tissue opaque mass in the left caudal lung lobe. Radiographs of all limbs showed extensive periosteal new bone formation of uniform opacity demonstrating a 'palisading' pattern. The lung mass was removed at exploratory thoracotomy; histopathological examination diagnosed a low-grade spindle cell sarcoma. Prior to surgery, the cat had a non-specific conjunctivitis that resolved spontaneously following lobectomy raising the possibility of a paraneoplastic association. The lameness also resolved; six months after surgery, the periosteal palisading of new bone on the long bones had remodelled, and there was no evidence of pulmonary metastases.

Entities:  

Year:  2003        PMID: 19379184     DOI: 10.1111/j.1476-5810.2003.00030.x

Source DB:  PubMed          Journal:  Vet Comp Oncol        ISSN: 1476-5810            Impact factor:   2.613


  3 in total

1.  Hypertrophic osteopathy in a cat with a concurrent injection-site sarcoma.

Authors:  Raquel Salgüero; Jackie Demetriou; Fernando Constantino-Casas; Michael Herrtage
Journal:  JFMS Open Rep       Date:  2015-07-06

2.  Renal adenocarcinoma associated with hypertrophic osteopathy in a cat.

Authors:  Sarah Elhamiani Khatat; Rosario Vallefuoco; Meryem El Mrini; Morgane Canonne-Guibert; Dan Rosenberg
Journal:  JFMS Open Rep       Date:  2020-11-22

3.  Hypertrophic osteopathy in a cat with cardiac interventricular septal defect.

Authors:  Felipe Auatt Batista de Sousa; Matheus Viezzer Bianchi; Paula Augusto Taunde; Marcele Bettim Bandinelli; Rochana Rodrigues Fett; David Driemeier; Saulo Petinatti Pavarini
Journal:  J Vet Sci       Date:  2019-09       Impact factor: 1.672

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.